Menu Search
Equities

Hoenle AG

  • Add to watchlist
  • Add to portfolio
  • Add an alert
HNL:STU

Hoenle AG

Actions
  • Price (EUR)8.62
  • Today's Change0.04 / 0.47%
  • Shares traded0.00
  • 1 Year change-9.26%
  • Beta1.2437
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hoenle AG, formerly Dr Hoenle AG, is a Germany-based company. The Company is engaged in three business units (BU): Adhesive Systems, Curing and Disinfection. The Adhesive Systems BU supplies industrial adhesives and Ultra-Violet (UV) light curing equipment for the electronics, medical technology, optics, and automotive sectors. The Curing BU sells equipment and installations for curing paints and coatings, these systems facilitate printers (particularly packaging printers), in surface coatings for floor coverings, in the furniture industry, in the automotive industry and in other industrial coating applications. It also offers lifecycle solutions. The Disinfection BU combines the business activities in the areas of water, surface, and air disinfection. The Disinfection segment also offers services such as microbiological analysis in addition to UV lamps and components. The Company operates globally with around 20 subsidiaries.

  • Revenue in EUR (TTM)93.68m
  • Net income in EUR-3.17m
  • Incorporated1999
  • Employees497.00
  • Location
    Hoenle AGNicolaus-Otto-Str. 2GILCHING 82205GermanyDEU
  • Phone+49 810520830
  • Fax+49 81 052083148
  • Websitehttps://www.hoenle.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.